Been watching this for a few weeks. Its filling the gap nicely, and seems to be good support buying around 3 cents.
Printable View
Been watching this for a few weeks. Its filling the gap nicely, and seems to be good support buying around 3 cents.
QUARTER: PIL: Significant Sales Growth Continues
The Directors of Promisia Integrative Limited (NZX:PIL) are pleased to advise
that sales for the third quarter of the current financial year ending 30
September 2016 have maintained the trend set in the first half year as
detailed in the company's announcement of it half year results on 30 August
2016. Sales for the third quarter were $833,009, which is a 590% increase on
sales in the same quarter in 2015.
Sales for the first 9 months of 2016 have been $1,827,009 compared with sales
of $262,716 for the same period in 2015, which is a 595% increase.
The directors are considering a modest capital raising to fund the marketing
of Arthrem in Australia in 2017 and the launch in 2017 of the canine
arthritis product in New Zealand and Australia.
This holder very happy today
Tiny amount of dollars though.
The canine version could be a winner. Plenty of owners will do whatever it takes to help their pets. Whereas human doctor visits and drugs may be subsidised that is not the case with vet bills and drugs. So although Arthrem might not be a cheap alternative for humans, it probably is for dogs. With the bonus of being natural.
Yep agree that the dollar amounts may be tiny but they are growing week by week and the chart looks good.
People who took up their rights earlier this year at 1 cent should be feeling pleased that they did. 1 cent to 4 cents....nothing else on the NZX touches that this year. And its not even a mining exploration stock.
PIL
11/11/2016 10:23
GENERAL
PRICE SENSITIVE
REL: 1023 HRS Promisia Integrative Limited
GENERAL: PIL: Year to Date Sales Exceed $2 million
The directors of Promisia Integrative Limited are pleased to advise that
total sales for the first 10 months of the year have exceeded $2 million.
Sales for the month of October exceeded $300,000 for the first time.
Final sales for the month of October were $325,587 from all sources but
mainly from sales in New Zealand. Sales for the 10 months to 31 October 2016
were $2,152,596, which is a 574% increase over same period sales in 2015.
For further information please contact:
Mr Stephen Underwood, Chairman, on 04 499 3412 or 027 499 3387
Mr Charles Daily, Chief Executive Officer, on 04 894 8524 or 021 643 906
End CA:00292523 For:PIL Type:GENERAL Time:2016-11-11 10:23:23
Wow, floated at 50 c back in the day, it does remind me of BLIS THAT FLOATED AT $1 .
my concern is that there is basically one product, with one scientist. If she got run over, what would happen to the company?
They must have things in place for that sort of thing ?
Any thoughts
Not just good for arthritis but cancer too...... Now this would be a good marketing strategy.......
"Research to develop antimalarial drugs led to the discovery of artemisinin, a compound which is extracted from Artemisia annua,( same plant that PIL use )
. It is proven, that artemisinin has anti-cancer activity as well, because it contains an endoperoxide group. Artemisinin has a high anti-cancer activity due to its interaction with iron complexes[37] in the blood. This shows that artemisinin derivatives induce apoptosis( death of ) of cancer cells as well.[38]"
not holding yet, but plan on some.